Webinar: Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery
May 9, 2017 (1 – 2 p.m. EDT)
Questions can be posed in advance to email@example.com.
This webinar will provide an overview of the R01 and R21 funding opportunity announcements, Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery PA-17-060 (R01) and PA-17-061 (R21).
These funding opportunities seek research to:
- assess and describe the current state of oral anticancer medication utilization, delivery, and adherence;
- identify structural, systemic, and psychosocial barriers to adherence; and
- develop models and strategies to improve safe and effective delivery of these agents so that clinical outcomes are optimized.
National Cancer Institute Speakers:
Basic Biobehavioral and Psychological Sciences Branch
Behavioral Research Program
Clinical and Translational Epidemiology Branch
Epidemiology and Genomics Research Program
Office of the Associate Director
Healthcare Delivery Research Program
Intended Audience: Extramural investigators at junior, mid-, and senior levels.
Email your questions in advance to firstname.lastname@example.org. Questions about specific aims or grant application details will not be addressed.